Case Study: Molecular Health improves drug data-driven decision making with DrugBank

Changing the Healthcare Ecosystem using Data-Driven Technology

Molecular Health, a biomedical intelligence company, needed comprehensive and structured drug data to power its data-driven healthcare products and overcome the challenges of fragmented, hard-to-harmonize information in drug discovery. To build its integrated drug resource, it turned to DrugBank as a primary data source.

DrugBank provided the critical structured data on drug structures, classifications, targets, and interactions. This solution allowed Molecular Health to seamlessly integrate and enrich its in-house data, forming the essential foundation for products like MH Predict. The results include a reliable, high-quality drug database that enhances the company's predictive analytics and supports its mission of improving diagnosis, therapy decisions, and clinical trial success predictions.

Molecular Health